期刊文献+

白念珠菌烯醇化酶N端肽段ENO1-319P的原核表达和鉴定 被引量:1

Expression and identification of N-terminal fragment of Candida albicans enolase
下载PDF
导出
摘要 目的制备白念珠菌烯醇化酶N端基因重组肽段ENO1-319P并检测其抗原性。方法选择与人烯醇化酶蛋白α-ENO同源性低的白念珠菌烯醇化酶肽段ENO1-319P,将其编码DNA序列克隆到表达载体pET28a(+),并在大肠埃希菌BL21(DE3)中用IPTG诱导带有His标签的重组肽段的表达。用SDS-PAGE电泳分析,TALON金属亲和层析柱纯化重组蛋白,其抗原性用侵袭性白念珠菌感染(ICAI)患者血清进行western blot评估。结果成功表达并纯化了目的肽段,该蛋白可与ICAI患者血清发生特异性反应。结论获得了白念珠菌烯醇化酶N端肽段ENO1-319P的基因表达工程菌株,为将此重组肽段用于制备特异性更高的抗体打下基础。 Objective To prepare the recombinant N-terminal fragment ENO1-319P of Candida albicans enolase and evaluate its antigenicity.Methods The DNA fragment encoding ENO1-319P,which showed low homology to the α-ENO1 of Homo sapiens enolase,was cloned into the prokaryotic expression vector pET28a(+).The recombinant peptide with His6 tag was then produced by the induction of IPTG in E.coli.BL21(DE3),purified by TALON metal affinity resins,and analyzed with SDS-PAGE.The immunogenicity of the recombinant peptide was evaluated by western blot with sera of patients with invasive candidiasis.Results The recombinant peptide was successfully expressed and purified.Western blot showed that the recombinant protein could specifically react with the sera from systemic candidiasis patients.Conclusion The engineering bacteria strain expressing recombinant N-terminal fragment of Candida albicans enolase was prepared successfully for the research on the recombinant peptide with high specificity.
出处 《临床检验杂志》 CAS CSCD 北大核心 2011年第6期419-421,共3页 Chinese Journal of Clinical Laboratory Science
基金 江苏省科技支撑计划-社会发展项目(BE2009673)
关键词 白念珠菌 烯醇化酶 N端肽段 原核表达 Candida albicans enolase N-terminal fragment prokaryotic expression
  • 相关文献

参考文献7

二级参考文献32

共引文献474

同被引文献26

  • 1Erjavec Z, Kluin-Nelemans H, Verweij PE. Trends in invasive fungal infections, with emphasis on invasive aspergillosis[J]. Clin Microbiol Infect, 2009, 15(7) :625-633.
  • 2Lau A, Chen S, Sleiman S, et al. Current status and future perspectives on molecular and serological methods in diagnostic mycology[ J ]. Future Microbiol, 2009, 4(9) :1185-4222.
  • 3Bellocchio S, Bozza S, Montagnoli C, et al. Immunity to Aspergillus fumigatus: the basis for immunotherapy and vaccination[ J ]. Med Mycol, 2005, 43(S1) : S181-S188.
  • 4Einsele H, Loeffler J. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients [ J ]. Clin Microbial Infect, 2008, 14( Suppl 4) :37-45.
  • 5Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination [ J ]. American J Clin Pathol, 2003, 119 (6) : 854-858.
  • 6Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis [ J ]. J Microbiol, 2005, 43:65-84.
  • 7Gerlinger MP, Rousselot P, Rigaudeau S, et al. False positive galactomannan Platelia due to piperacillin-tazobactam [ J ]. Med Mal Infect, 2012, 42(1) :10-14.
  • 8Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients [ J ]. Pediatr Infect Dis J, 2007, 26 (7) : 558-564.
  • 9Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis[J]. Clin Infect Dis, 2006, 42 (10) : 1417-1427.
  • 10Trof R J, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients [J]. Intens Care Med, 2007, 33 (10) :1694-1703.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部